December 21, 2014 9:34 AM ET

Biotechnology

Company Overview of Link Medicine Corporation

Executive Profile

Peter T. Lansbury Jr., Ph.D.

Chief Scientific Officer, Lysosomal Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Peter T. Lansbury, Jr., Ph.D. serves as Chief Scientific Officer at Lysosomal Therapeutics Inc. Dr. Lansbury was a Co-founder of Link Medicine Corporation and served as Chief Scientific Officer. Dr. Lansbury serves as an Associate Professor of Neurology of Harvard Medical School. Dr. Lansbury served as Director of the Brigham and Women's Hospital Morris K. Udall Center of Excellence in Parkinson's Disease Research and chair of the Harvard Laboratory for Drug Discovery ...

Corporate Headquarters

161 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-583-1060
Fax: --

Board Members Memberships

Co-Founder and Director

Education

PhD
Harvard University
BA
Princeton University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Link Medicine Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.